Oblimersen

DB13811InvestigationalSmall molecule

Oblimersen: Overview.

Resolves to

Compound
UNII85J5ZP6YSLCAS190977-41-4
Clinical / RWD
ATCL01XX36
Targets
P10415BCL2

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 16 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Oblimersen, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In